Omar Abed

Omar Abed at a forest

Co-advised by Dr. Peter Tessier and Dr. Colin Greineder.


PhD Student, Chemical Engineering, 2021-present
MS, Chemical Engineering, Arizona State University, 2021
BSE, Chemical Engineering, Arizona State University, 2020


Protein engineering for the targeted delivery of therapeutics

  • Antibody engineering
  • Targeted drug delivery
  • Inflammatory bowel disease (IBD)
  • Autoimmune diseases
  • Gut microbiome


Engineering targeted IL-2 mutein fusion proteins for the treatment of IBD.


Camping, hiking, fishing, playing board games, learning new languages.


  1. Kim, A.*; Xie, F.*; Abed, O.A.; Moon, J.J.§. Vaccines for immune tolerance against autoimmune disease. ADDR 2023, 203. Link PDF
  2. Abed, O.A.*; Attlassy, Y.*; Xu, J.; Han, K.; Moon, J.J. Emerging Nanotechnologies and Microbiome Engineering for the Treatment of Inflammatory Bowel Disease. Mol Pharm 2022. Link PDF
  3. Thompson, B.*; Machas, M.*; Abed, O.; Nielsen, D.R. Applying a ‘Metabolic Funnel’ for Phenol Production in Escherichia coli. Fermentation 2021, 7 (4), 216.
  4. Machas, M.; Kurgan, G.; Abed, O.A.; Shapiro, A.; Wang, X.; Nielsen, D.R. Characterizing Escherichia coli’s Transcriptional Response to Different Styrene Exposure Modes Reveals Novel Toxicity and Tolerance Insights. J of Ind Microbiol and Biotechnol 2021, 48 (1-2).